+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Osteoarthritis Therapeutics - Global Market Trajectory & Analytics

  • ID: 5303627
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Eli Lilly
  • Flexion Therapeutics
  • Horizon Therapeutics
  • Novartis
  • MORE
Global Osteoarthritis Therapeutics Market to Reach $11.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Osteoarthritis Therapeutics estimated at US$7.1 Billion in the year 2020, is projected to reach a revised size of US$11.4 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Knee, one of the segments analyzed in the report, is projected to record a 7.6% CAGR and reach US$5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hip segment is readjusted to a revised 6.9% CAGR for the next 7-year period.



The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 10.5% CAGR

The Osteoarthritis Therapeutics market in the U.S. is estimated at US$1.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2027 trailing a CAGR of 10.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Hand Segment to Record 6.1% CAGR

In the global Hand segment, USA, Canada, Japan, China and Europe will drive the 5.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.5 Billion by the year 2027, while Latin America will expand at a 7.3% CAGR through the analysis period.

Select Competitors (Total 34 Featured):
  • Abbott
  • Anika Therapeutics
  • Bayer AG
  • Bioventus
  • Eli Lilly
  • Fidia Farmaceutici s.p.a.
  • Flexion Therapeutics
  • GlaxoSmithKline Plc
  • Horizon Therapeutics
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Sanofi
  • Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Eli Lilly
  • Flexion Therapeutics
  • Horizon Therapeutics
  • Novartis
  • MORE
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
IV. COMPETITION
  • Total Companies Profiled: 34
Note: Product cover images may vary from those shown
  • Abbott
  • Anika Therapeutics
  • Bayer AG
  • Bioventus
  • Eli Lilly
  • Fidia Farmaceutici s.p.a.
  • Flexion Therapeutics
  • GlaxoSmithKline Plc
  • Horizon Therapeutics
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Sanofi
  • Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll